UK stakeholders' views of pharmacist supplementary prescribing - benefits, barriers, facilitators and challenges

• In: CPS 5. Other - Posters
• At: Beijing (China) (2007)
• Type: Poster
• Poster code: CPS5-P-006
• By: ANDERSON, Claire (Univeristy of Nottingham, Nottingham, United Kingdom)
• Co-author(s): Cooper, Richard (Univeristy of Nottingham, Nottingham, United Kingdom)
  Guillaume, Louise (University of Sheffield, Sheffield, United Kingdom)
  Bissell, Paul (University of Sheffield, Sheffield, United Kingdom)
  Avery, Tony (Univeristy of Nottingham, Nottingham, United Kingdom)
  Hutchinson, Allen (University of Sheffield, Sheffield, United Kingdom)
  McIntosh, Aileen (University of Sheffield, Sheffield, United Kingdom)
  Murphy, Elizabeth (Univeristy of Nottingham, Nottingham, United Kingdom)
  Lymn, Joanne (Univeristy of Nottingham, Nottingham, United Kingdom)
  James, Veronica (Univeristy of Nottingham, Nottingham, United Kingdom)
  Read, Susan (Univeristy of Nottingham, Nottingham, United Kingdom)
  Ward, Paul (Flinders University, Adelaide, Australia)
  
• Abstract:

  Pharmacist and nurse supplementary prescribing (SP) has been in place since 2003 [1] in England and is central to National Health Service (NHS) aims of improving patients' access to medicines and better utilising the skills of health care professionals [2.] Pharmacist SP impacts upon many groups and the aim in this research was to identify the

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login